Laxmi Dental Share Price

Healthcare Supplies company Laxmi Dental announced Q4FY26 & FY26 results Consolidated Financial Highlights: Total Income: For Q4FY26, total income was Rs 763.14 million, representing a YoY incroreease of 22.50% from Rs 622.99 million in Q4FY25 and a QoQ incroreease of 12.03% from Rs 681.17 million in Q3FY26. Revenue from Operations: In Q4FY26, revenue stood at Rs 739.54 million, up 21.90% YoY from Rs 606.68 million and up 11.98% QoQ from Rs 660.40 million. Profit Before Tax: For Q4FY26, PBT was Rs 111.35 million, compared to Rs 60.10 million in Q4FY25 and a loss of Rs 12.28 million in Q3FY26. Net Profit: The company reported a consolidated net profit of Rs 100.94 million in Q4FY26, compared to Rs 42.75 million in Q4FY25 and Rs 19.59 million in Q3FY26. Annual Performance: For the full year FY26, total income reached Rs 2,864.04 million, growing 18.13% YoY from Rs 2,424.45 million in FY25. Revenue from operations for FY26 reached Rs 2,778.58 million, up 16.21% from Rs 2,391.07 million in FY25. Annual Net Profit: For FY26, net profit stood at Rs 289.17 million, compared to Rs 318.34 million in FY25, showing a YoY decroreease of 9.16%. Earnings Per Share (EPS): Annual Basic EPS for continuing operations stood at Rs 5.27 in FY26 compared to Rs 6.20 in FY25. Standalone Financial Highlights: Total Income: Standalone total income for Q4FY26 reached Rs 577.26 million, up 28.67% YoY from Rs 448.63 million and up 14.41% QoQ from Rs 504.57 million in Q3FY26. Revenue from Operations: For Q4FY26, revenue was Rs 557.36 million, a growth of 30.57% YoY compared to Rs 426.85 million in Q4FY25. Profit Before Tax: For Q4FY26, standalone PBT was Rs 65.81 million, compared to Rs 64.03 million in Q4FY25 and a loss of Rs 18.81 million in Q3FY26. Net Profit: Standalone net profit for Q4FY26 reached Rs 67.98 million, compared to Rs 41.75 million in Q4FY25 and a loss of Rs 18.90 million in Q3FY26. Annual Performance: Standalone total income for FY26 grew by 23.15% to Rs 2,165.82 million from Rs 1,758.64 million in FY25. Annual Net Profit: Full-year standalone net profit was Rs 193.37 million in FY26 compared to Rs 257.75 million in FY25. Business Highlights Segment Performance (Consolidated FY26): Laboratory Business: This segment remains the primary revenue driver, contributing Rs 1,968.72 million in FY26, a 27.70% YoY incroreease from Rs 1,541.62 million in FY25. Aligners Business: Segment revenue stood at Rs 766.52 million in FY26, compared to Rs 808.51 million in FY25. Other Business: Revenue for this segment was Rs 86.41 million in FY26. Exceptional Items: The company accounted for an estimated incroreemental impact of the New Labour Codes as an exceptional item, amounting to Rs 57.79 million (consolidated) and Rs 51.56 million (standalone) for FY26. IPO Proceeds Utilization: As of March 31, 2026, the company has utilized Rs 735.07 million of its IPO proceeds. The remaining unutilized amount of Rs 546.63 million is temporarily invested in fixed deposits with banks. Strategic Corporate Actions: The Board of Directors approved a Scheme of Merger between Bizdent Devices Private Limited (a wholly-owned subsidiary) and Laxmi Dental Limited. The Group strategically discontinued the business operations of Rich Smile Design LLP during the year. The company acquired additional shares in Bizdent Devices Private Limited via a rights issue for Rs 409.15 million and invested Rs 13.72 million in IDBG AI Dent Global Private Limited. International Expansion: The company entered into an investment agreement with Laxmi Dental Lab USA INC for additional equity shares totaling USD 1,000,000 to support business growth and working capital. Rajesh Khakhar, Chairperson and Whole-Time Director said, “I am pleased to share that Laxmi Dental closed the year with a strong exit quarter, delivering highest-ever quarterly numbers acroreoss key metrics. Revenue for Q4FY26 stood at Rs 74.0 crore, representing YoY growth of 21.9%. EBITDA and PAT Margins for the quarter were recorded at healthy levels of 18.3% and 13.6%, respectively, even with a higher US tariff in first half of the quarter. Our Full year revenue stood at Rs 278 crore with EBITDA margin of 15.6% and PAT margin of 10.4%. The performance is despite multiple operational challenges pertaining to macroreo-economic environment and geopolitical situations. With continuous efforts towards digitalization, our digital penetration levels for Indian Dental business stands at ~80%. Our performance is a testimony of continued efforts towards business expansion, strategic innovation, the inherent strength of our core dental operations, and sustained investments in branding and product development. We will move forward on the same principles and will continue our efforts towards accelerating adoption of digital dentistry.” Sameer Merchant, Managing Director and CEO said, “I am happy to announce that the company delivered a solid quarterly performance which is broad based acroreoss all segments. Our Dental Laboratory business reported its highest-ever quarterly performance, delivering a robust 27% YoY growth. This growth was driven by a strong recovery in the domestic business, coupled with highest-ever revenue from our international operations. The Aligner Solutions business also delivered a healthy performance, reporting revenue of Rs 18 crore during the quarter. Within this segment, Bizdent, our clear aligner business, witnessed a meaningful recovery and recorded a healthy 11% YoY growth. Vedia, our aligner raw material business, remained stable sequentially and reported revenue of Rs 7 crore. We saw some order delays in this business due to higher freight costs in the month of March pertaining to geopolitical uncertainties. The performance acroreoss businesses is a result of the consistent efforts of our sales and operations teams. We believe all the segments hold significant growth opportunities and with our strong product range and market positioning, we are well placed to capitalize on the growing demand for this product.” Result PDF

• Trendlyne
• 1 week 1 day ago

Healthcare Supplies company Laxmi Dental announced Q3FY26 results Revenue: Rs 660.4 million against Rs 616.6 million during Q3FY25, change 7%. EBITDA: Rs 69.7 million against Rs 96.1 million during Q3FY25, change -27%. EBITDA Margin: 10.6% for Q3FY26. PBT: Rs 45.5 million against Rs 47.1 million during Q3FY25, change -3%. Rajesh Khakhar, Chairperson & Whole-Time Director, said: “In Q3FY26, the company delivered revenues of Rs 660 million as against Rs 61.7 crore in same period last year, recording a YoY growth of 7%. The performance is despite global macroeconomic and geopolitical challenges, underscoring the strength and resilience of our diversified portfolio. Gross profit margins witnessed minor improvement sequentially due to steady profitability in the laboratory and aligner business alongside a relatively lower contribution of scanner sales, which are low margin in nature. Scanner sales hold strategic importance for future growth across segments. During Q3, we had a full quarter impact of 150 bps on account of higher US tariffs. Additionally, we recorded a one-time exceptional provision of Rs 58 million towards gratuity past service liability under the new labour code. With US tariff normalization, positive development of EU FTA, multiple ongoing strategic initiatives, and consolidation in the domestic dental market, Laxmi Dental is well positioned to deliver resilient, industry-leading growth along with improved profitability going ahead.” Sameer Merchant, Managing Director & CEO, said: “For Q3FY26, our Dental lab business recorded a decent YoY growth of 10.4%, with international business delivering robust 25.5% YoY growth, while the domestic lab remained soft. Towards this, we have implemented innovative strategies in the quarter, and that has started showing positive results in the month of January 2026. Within the Aligner Solutions business, the competitive pricing pressures on Bizdent is getting normalized in the running quarter, Q4FY26, and we anticipate the situation to remain positive for the entire quarter. With the new strategic initiatives, we are seeing a strong recovery in our domestic dental lab and Bizdent businesses, and we expect both these segments to deliver robust YoY performance in Q4FY26. On the back of these positive trends, we expect to close FY26 with a healthy exit quarter and begin FY27 on a stronger footing. Over long-term, we remain committed towards promoting digital dentistry and spearheading this revolution for the entire dental industry in India on the back of our scanner solutions.” Result PDF

• Trendlyne
• 3 months 2 weeks ago

Healthcare Supplies company Laxmi Dental announced Q2FY26 results Highest ever quarterly revenue in Q2FY26. Delivering growth of 26.5% YoY and 10.2% QoQ. In Q2 FY26, scanner sales which are typically at lower margins were pushed in alignment with long-term digitalization and growth strategy. Increase in employee expenses is on account of annual increments. ESOP expenses, which are non-cash in nature, stood at Rs 16.76 Mn for Q2FY26 and it is expected to be Rs 63.4 Mn for FY26. Rs 66.2 Mn worth of exceptional Item pertaining to gain on property sale was recorded in Q1FY25. Therefore, H1FY25 is a non-comparable higher base. Rajesh Khakhar, Chairperson & Whole-Time Director, said: “Q2FY26 marked another quarter with strongest ever sales for Laxmi Dental, growing 26.5% YoY. Despite global uncertainties, our resilient business model and strategic focus enabled us to maintain decent profitability, with EBITDA margin at 15.3% and PAT margin at 11.8%. Scanner sales jumped 94.7% YoY, with the number of units sold in the first half of FY26 already crossing the number of units sold in the entire year of FY25. These scanner sales are strategic in nature and continue to drive digital transformation across our dental network and laying the foundation for future growth. With a focus on digital dentistry and AI, we remain committed towards innovation, operational excellence, and capturing emerging opportunities in the dental industry.” Sameer Merchant, Managing Director & CEO, said: “Our sustained performance highlights the strength of our portfolio and the effectiveness of our strategic initiatives. Adjusted for scanner sales, our segmental performance reflected a broadbased growth. Dental lab business grew 29.9% YoY, driven by a continued traction in both domestic as well as international markets. The aligner solutions segment recorded a 12.3% YoY growth, primarily driven by ‘Taglus’, which recorded an impressive 29.9% YoY growth. On a YoY basis, our clear aligner business, ‘Bizdent’, sustained at similar levels, due to competitive pressures. However, on a QoQ basis, Bizdent recorded a growth of 10.9% Kids-E-Dental, showed signs of recovery with a 21.4% QoQ growth. We anticipate accelerated momentum in this business once registration processes are cleared for multiple international geographies. We continue to invest in automation, R&D;, and brand building. With rising dental awareness, regulatory tailwinds, and market consolidation, we are well-positioned to sustain our growth trajectory and deliver long-term value to stakeholders." Result PDF

• Trendlyne
• 6 months 2 weeks ago